Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance
Highly Active Antiretroviral Therapy (HAART) is the most effective way to control HIV-1 replication in infected patients. Prior to the start of therapy, genotyping of HIV-1 for mutations that confer resistance to potential drug candidates is crucial for it allows formulating an effective regimen. In...
Saved in:
Main Authors: | Palanee Ammaranond, Sayompoo Sanguansittianant, Paul A. Raju, Philip Cunningham, Navin Horthongkham |
---|---|
Other Authors: | Chulalongkorn University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/33976 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Prevalence of HIV-1 subtypes and antiretroviral drug resistance mutations in nepal
by: Nirajan Bhusal, et al.
Published: (2018) -
Prevalence of primary HIV drug resistance in Thailand detected by short reverse transcriptase genotypic resistance assay
by: Sasisopin Kiertiburanakul, et al.
Published: (2018) -
Molecular characterization of drug resistance and subtype diversity in HIV-1 infected patients : Implication for subtype-specific mutational pathway on protease and reverse transcriptase genotype
by: Chonlaphat Sukasem
Published: (2023) -
Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals
by: Awachana Jiamsakul, et al.
Published: (2018) -
Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals
by: Jiamsakul A., et al.
Published: (2017)